An investigation on behalf of investors in Armata Pharmaceuticals Inc. (NYSE:ARMP) shares over potential wrongdoing at Armata Pharmaceuticals Inc. was announced and NYSE:ARMP stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 05/20/2021 -- An investigation on behalf of investors in shares of Armata Pharmaceuticals Inc. (NYSE: ARMP) was announced over potential breaches of fiduciary duties by certain officers and directors at Armata Pharmaceuticals Inc. .
Investors who purchased shares of Armata Pharmaceuticals Inc. (NYSE: ARMP) have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Armata Pharmaceuticals Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
Marina del Rey, CA based Armata Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for the treatment of antibiotic-resistant infections worldwide. Armata Pharmaceuticals Inc. (NYSE: ARMP) declined from $6.50 per share in February to $3.83 per share on May 10, 2021.
Those who purchased shares of Armata Pharmaceuticals Inc. (NYSE: ARMP), have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.